Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Human TRIO Antibody (SAA1532)

Catalog #:   RHB37401 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: ELISA
Accession: O75962
Overview

Catalog No.

RHB37401

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

TRIO, Triple functional domain protein, PTPRF-interacting protein

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

O75962

Applications

ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA1532

Data Image
References

Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial., PMID:40483169

Common variable immunodeficiency due to a novel variant in NFKB1 with a neonatal presentation of parechovirus meningitis and sepsis-like illness., PMID:40342112

Case Report: de novo in-frame deletion in PLCG2 gene: a case report of B-cell lymphopenia, pulmonary bullae, and cutis laxa., PMID:40170866

Virus-like particle-based vaccines targeting the Anopheles mosquito salivary protein TRIO., PMID:39878467

Trio-based exome sequencing and high-resolution HLA typing in families of patients with autoimmune adrenal insufficiency and autoimmune polyglandular syndrome., PMID:39423205

Virus-like particle-based vaccines targeting the Anopheles mosquito salivary protein, TRIO., PMID:39282324

Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial., PMID:39271844

Vitamin K Antagonists for Pregnant Women With Antiphospholipid Antibodies: A Scoping Review., PMID:39089838

Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis., PMID:39009890

In vivo mRNA expression of a multi-mechanistic mAb combination protects against Staphylococcus aureus infection., PMID:38822525

Follow-up to Adolescence after Early Peanut Introduction for Allergy Prevention., PMID:38804779

Cadherin-17 as a target for the immunoPET of adenocarcinoma., PMID:38625402

Detection of infliximab, adalimumab, and anti-drug antibodies: Development and validation of new monotest, automated assays on multiparametric instrument., PMID:38463198

Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network-Breast dataset (SCAN-B)., PMID:38442452

Thiamine-Responsive Megaloblastic Anaemia With Hypothyroidism, A Puzzling Association., PMID:38406914

Intravenous immunoglobulin for patients with unexplained recurrent implantation failure: a 6-year single center retrospective review of clinical outcomes., PMID:38365988

Evaluation of the efficacy of Simparica Trio® in the prevention of the transmission of Babesia canis by infected Dermacentor reticulatus to dogs., PMID:38308372

Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype., PMID:38287413

Trio fluorophore-based phenotypic assay for the detection of artemisinin-induced growth-arrested Plasmodium falciparum in human erythrocytes., PMID:38245618

A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies., PMID:38170160

Co-Occurring Thrombotic Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia in a Child Carrying the Pathogenic SHOC2 c.4A>G (p.Ser2Gly) Variant., PMID:38019730

COPA syndrome caused by a novel p.Arg227Cys COPA gene variant., PMID:37877458

A Tangled Autoimmune Trio: Multiple Sclerosis, Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antineutrophil Cytoplasmic Antibody Vasculitis., PMID:37850606

ACOX1 Gain-of-Function Variant in Two German Pediatric Patients, in One Case Mimicking Autoimmune Inflammatory Disease., PMID:37846133

A missense variant in DGKG as a recessive functional variant for hepatic fibrinogen storage disease in Wagyu cattle., PMID:37681469

2023 ACR/EULAR antiphospholipid syndrome classification criteria., PMID:37640450

The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria., PMID:37635643

Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss., PMID:37491929

Preclinical and clinical activity of DZD1516, a full blood-brain barrier-penetrant, highly selective HER2 inhibitor., PMID:37415239

How to solve a clinical conundrum: Have you tried a trio exome analysis?, PMID:37407083

Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results., PMID:37390764

Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer., PMID:37302750

Developing a Prediction Model for Determination of Peanut Allergy Status in the Learning Early About Peanut Allergy (LEAP) Studies., PMID:37146884

Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab., PMID:37103916

High-sensitivity cardiac troponin T in infants exposed to anti-Ro antibodies., PMID:36912668

Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial., PMID:36898233

Clinical application of trio-based whole-exome sequencing in idiopathic generalized epilepsy., PMID:36842888

Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer., PMID:36709663

WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1., PMID:36672344

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial., PMID:36495879

T-DXd Keeps Shining in Breast Cancer., PMID:36484540

Characterization of Neutralizing Human Anti-Tetanus Monoclonal Antibodies Produced by Stable Cell Lines., PMID:36297421

Case report: A study on the de novo KMT2D variant of Kabuki syndrome with Goodpasture's syndrome by whole exome sequencing., PMID:36090579

A risk stratification model for toxicities in phase 1 immunotherapy trials., PMID:36084619

Anti-desmoglein 1 antibody-positive mother and antibody-negative child with Darier's disease., PMID:36074695

Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A., PMID:36000620

Lysine-Directed Site-Selective Bioconjugation for the Creation of Radioimmunoconjugates., PMID:35946495

Nfkb2 deficiency and its impact on plasma cells and immunoglobulin expression in murine small intestinal mucosa., PMID:35916405

Cancer vaccines., PMID:35700704

Identification and selection of healthy spermatozoa in heterozygous carriers of the Phe508del-variant of the CFTR-gene in assisted reproduction., PMID:35115637

Datasheet
$ 328
Product specifications
100 μg 328 1 mg 1640

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human TRIO Antibody (SAA1532) [RHB37401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only